506820 logo

AstraZeneca Pharma India Limited Stock Price

BSE:506820 Community·₹195.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

506820 Share Price Performance

₹7,817.70
-274.30 (-3.39%)
₹7,817.70
-274.30 (-3.39%)
Price ₹7,817.70

506820 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Outstanding track record with adequate balance sheet.

1 Risk
1 Reward

AstraZeneca Pharma India Limited Key Details

₹21.8b

Revenue

₹12.5b

Cost of Revenue

₹9.3b

Gross Profit

₹7.2b

Other Expenses

₹2.0b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 30, 2026
80.36
42.52%
9.23%
4.4%
View Full Analysis

About 506820

Founded
1979
Employees
600
CEO
Praveen Akkinepally
WebsiteView website
www.astrazeneca.in

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cardiovascular, renal, metabolic, and immunological conditions; oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names. The company also offers medicines for diabetes; and clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

Recent 506820 News & Updates

Recent updates

No updates